# Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture

> **NCT06949137** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **HELP Therapeutics Co., Ltd.** · enrollment: 9 (actual)

## Conditions studied

- Osteoporosis in Post-menopausal Women
- Osteoporosis

## Interventions

- **BIOLOGICAL:** Human Umbilical Cord-derived Mesenchymal stem cell

## Key facts

- **NCT ID:** NCT06949137
- **Lead sponsor:** HELP Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-03-06
- **Final completion:** 2026-09-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06949137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06949137, "Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06949137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*